20 january, 2021 13.20
Nowadays the world is actively discussing new opportunities for collecting data for pharmacovigilance and there are various projects already that in the near future may become a usual everyday occurrence in Ukraine, said Alexander Torgun, the head of the department for regulatory issues of "Darnitsa" pharmaceutical company.
18 january, 2021 19.04
To compile the rating, its authors interviewed 11 thousand people and 150 large Ukrainian companies.
23 december, 2020 15.30
Business has to adapt, find other forms of cooperation with clients, use innovations, digital technologies because of the coronavirus pandemic, said the chairman of the Board of Darnitsa Group Dmytro Shymkiv.
22 january, 2019 19.32
Generics are cheaper than original medicines and they comprise the majority of drugs in Ukraine, but intellectual property law in Ukraine does not allow commencing generic drug development before international patent for original substance is not expired, declared Svitlana Didenko, the Member of the Supervisory Council of PrJSC “Pharmaceutical firm Darnitsa”.